Skip to content

Can a one-off administration of psilocybin reduce alcohol intake in patients with alcohol use disorder? A randomized, double-blinded, placebo-controlled clinical trial.

Status
Recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-517497-17-01
Acronym
PSILO4ALCO
Enrollment
100
Registered
2024-11-14
Start date
2023-09-01
Completion date
Unknown
Last updated
2026-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Use Disorder

Brief summary

Percentage of heavy drinking days during the last 28 days. A heavy drinking day is defined as a day with an excess intake of 60/48 grams (men/women) of alcohol per day. Data will be registered via TLFB.

Detailed description

Total alcohol consumption (gram/day) during the last 28 days. Data will be registered via TLFB., Percentage of days without any alcohol consumption during the last 28 days. Data will be registered via TLFB., Penn Alcohol Craving Scale (PACS) score., Alcohol Use Disorders Identification Test (AUDIT) score., Drug Use Disorders Identification Test (DUDIT) score., Alcohol Abstinence Self-efficacy (AASE) score., Quality of life (SF-36) score., Major Depression Inventory (MDI) score., Mindful Attention Awareness Scale (MAAS) score., NEO Personality Inventory score., Acceptance and Action Questionnaire score., Fagerström Test for Nicotine Dependence (FTND) score., Phosphatidyl-ethanol (PEth)., Liver parameters gamma-glutamyltransferase (GGT), alanine aminotransferase (ALAT) and mean corpuscular volume (MCV)., Brain-derived neurotrophic factor (BDNF)., Markers of inflammation (TNF-a and IL-6)., Pharmacokinetic properties of plasma psilocin., Key phenomena of the acute subjective experience assessed by questionnaires including the Mystical Experience Questionnaire (MEQ30), 11-Dimensional Altered State of Consciousness (11D-ASC)51, Emotional Breakthrough Inventory (EBI), Ego-dissolution Inventory (EDI), The Awe Experience Scale (AES) and the Experience of Music (EM) as well as qualitative analysis of video/audio recordings (before, during and after the psilocybin session)., Changes in emotional response to music as rated by the Geneva Emotional Music Scale (GEMS) and qualitative descriptions obtained by semi-structured interviews., Persisting Effects Questionnaire (PEQ) score, Post dosing fMRI analysis including differences in functional connectivity during resting state and task-related activity between treatment groups.

Interventions

Sponsors

Region Hovedstaden
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
Percentage of heavy drinking days during the last 28 days. A heavy drinking day is defined as a day with an excess intake of 60/48 grams (men/women) of alcohol per day. Data will be registered via TLFB.

Secondary

MeasureTime frame
Total alcohol consumption (gram/day) during the last 28 days. Data will be registered via TLFB., Percentage of days without any alcohol consumption during the last 28 days. Data will be registered via TLFB., Penn Alcohol Craving Scale (PACS) score., Alcohol Use Disorders Identification Test (AUDIT) score., Drug Use Disorders Identification Test (DUDIT) score., Alcohol Abstinence Self-efficacy (AASE) score., Quality of life (SF-36) score., Major Depression Inventory (MDI) score., Mindful Attention Awareness Scale (MAAS) score., NEO Personality Inventory score., Acceptance and Action Questionnaire score., Fagerström Test for Nicotine Dependence (FTND) score., Phosphatidyl-ethanol (PEth)., Liver parameters gamma-glutamyltransferase (GGT), alanine aminotransferase (ALAT) and mean corpuscular volume (MCV)., Brain-derived neurotrophic factor (BDNF)., Markers of inflammation (TNF-a and IL-6)., Pharmacokinetic properties of plasma psilocin., Key phenomena of the acute subjective experience ass

Countries

Denmark

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026